J. van Echten
University of Groningen
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by J. van Echten.
Cancer Genetics and Cytogenetics | 1993
R.F. Suijkerbuijk; R.J. Sinke; A.M. Meloni; Jennifer M. Parrington; J. van Echten; B. de Jong; J.W. Oosterhuis; Avery A. Sandberg; A. Geurts van Kessel
Human testicular germ-cell tumors (TGCTs) comprise a heterogeneous group of solid neoplasms. These tumors are characterized by the presence of a highly specific chromosomal abnormality, i.e., an isochromosome of the short arm of chromosome 12. At present, this i(12p) chromosome is found in more than 80% of TGCTs. Isochromosome 12p has also been observed in some ovarian and extragonadal germ cell tumors. In the remaining so-called i(12p)-negative TGCTs other abnormalities involving chromosome 12, mainly 12p, can be found. In order to establish whether 12p abnormalities other than i(12p) are a common phenomenon in TGCTs, a panel of 11 i(12p)-negative tumors was investigated using multicolor fluorescence in situ hybridization. All TGCTs examined appeared to contain chromosomal abnormalities involving 12p, resulting in a distinct overrepresentation of short arm sequences. In addition, indications were obtained for a clonal evolution in one of the tumors. Our data suggest that the occurrence of 12p abnormalities is a common phenomenon in i(12p)-negative TGCTs and that these abnormalities, analogous to i(12p), may contribute to the process of tumor development.
Cancer Genetics and Cytogenetics | 1996
M.C. Mostert; M.H.J. van de Pol; D. Olde Weghuis; R.F. Suijkerbuijk; A. Geurts van Kessel; J. van Echten; J.W. Oosterhuis; L.H.J. Looijenga
Comparative genomic hybridization (CGH) was carried out on 15 primary testicular germ cell tumors (TGCT) of adolescents and adults and two metastatic residual tumors after chemotherapeutic treatment. The results were compared with karyotypic data obtained form the same tumor specimens after direct harvesting of metaphases or short-term in vitro culture. Both techniques revealed that the most consistent abnormality in primary TGCT is gain of 12p-sequences. Although in most cases over-representation of the complete short arm was observed, CGH revealed a specific amplification of 12p11.1-p12.1 region in two independent primary tumors. In addition, loss of (parts of) chromosome 13 (always involving q31-qter), and gain of (parts of) chromosome 7 (mostly involving q11), (parts of) chromosome 8, and the X chromosome were detected in more than 25% of the tumors by this latter technique. Loss of 6q15-q21 in both residual tumors analyzed may suggest a role for this anomaly in acquired resistance to chemotherapeutic treatment. Overall, the CGH analyses confirmed gains and losses of certain chromosomal regions in TGCT as observed by karyotyping, and thus support their role in the development of these neoplasms. The amplification of a restricted region of 12p in primary TGCT confirms and extends our previous observations and, as such, represents an important step forward in the identification of gene(s) on 12p relevant for the pathogenesis of these tumors.
Cancer Genetics and Cytogenetics | 1991
A. Hamers; B. de Jong; R.F. Suijkerbuijk; A.H.M. Geurts van Kessel; J.W. Oosterhuis; J. van Echten; J. Evers; F. Bosman
Cytogenetic analysis of a primary germ-cell tumor originating from the streak gonad of a 20-year-old phenotypic female with a 46,XY karyotype and mixed gonadal dysgenesis revealed a 48,XY, +7, +i(12p) chromosomal pattern. Germ-cell tumors originating from gonads of normal males are usually highly aneuploid. An isochromosome 12p as well as an overrepresentation of chromosome 7 material are among the specific changes most consistently observed. The present case shows that tumors of dysgenetic gonads, albeit being near-diploid, may exhibit similar chromosomal changes. This observation lends additional support to the hypothesis that these specific cytogenetic anomalies may play an important role in the pathogenesis of human germ-cell tumors.
Oncogene | 1998
M.C. Mostert; A. Verkerk; M.H.J. van de Pol; J. Heighway; P. Marynen; Carla Rosenberg; A. G. Van Kessel; J. van Echten; B. de Jong; J.W. Oosterhuis; L.H.J. Looijenga
Cancer Genetics and Cytogenetics | 1996
M.C. Mostert; M.H.J. van de Pol; J. van Echten; D. Olde Weghuis; A. Geurts van Kessel; J.W. Oosterhuis; L.H.J. Looijenga
Genes, Chromosomes and Cancer | 1995
J. van Echten; B. de Jong; R.J. Sinke; D. Olde Weghuis; D.Th. Sleijfer; J.W. Oosterhuis
Prenatal Diagnosis | 2002
Birgit Sikkema-Raddatz; J. van Echten; J. van der Vlag; Charles H.C.M. Buys; G. J. Te Meerman
American Journal of Human Genetics | 1997
Carla Rosenberg; M.C. Mostert; M.H.J. van de Pol; Tb Schut; J. van Echten; B. de Jong; Anton K. Raap; L.H.J. Looijenga
American Journal of Human Genetics | 1997
Carla Rosenberg; M.C. Mostert; M.H.J. van de Pol; Tb Schut; J. van Echten; B. de Jong; Anton K. Raap; L.H.J. Looijenga
Cancer Genetics and Cytogenetics | 1994
R.F. Suijkerbuijk; R.J. Sinke; A.M. Meloni; Jennifer M. Parrington; J. van Echten; B. de Jong; J.W. Oosterhuis; Sérgio Castedo; Lúcia Roque; G. Soares; Avery A. Sandberg; A. Geurts van Kessel